Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs

BACKGROUND: Systemic inflammation response index (SIRI) has been reported to be an effective blood-based biomarker for predicting prognosis in various kinds of cancer patients. However, the prognostic role of SIRI in advanced lung adenocarcinoma patient remains unclear. METHODS: The aim of the prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shun, Wang, Sisi, Wang, Qianqian, Deng, Chao, Feng, Yuhua, Ma, Fang, Ma, Jin’an, Liu, Xianling, Hu, Chunhong, Hou, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900776/
https://www.ncbi.nlm.nih.gov/pubmed/33633464
http://dx.doi.org/10.2147/CMAR.S287897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900776/
https://www.ncbi.nlm.nih.gov/pubmed/33633464
http://dx.doi.org/10.2147/CMAR.S287897

Ejemplares similares